Article
Analysis of pluripotency transcription factor interactions reveals preferential binding of…
medRxiv · 2022 · Mistri, T. K.; Kelly, D.; Mak, J.; Colby, D.; Mullin, N.; Chambers, I.
Key facts
| Title | Analysis of pluripotency transcription factor interactions reveals preferential binding of NANOG to SOX2 rather than NANOG or OCT4 |
|---|---|
| First author | Mistri, T. K.; Kelly, D.; Mak, J.; Colby, D.; Mullin, N.; Chambers, I. |
| Journal | medRxiv |
| Published | Sep 23, 2022 |
| DOI | 10.1101/2020.06.24.169185 |
| Devices mentioned | BK110039, DEN000008, K022086, K103302 |
| Product codes mentioned | JCI, KIT, LYE, NDS, NJT, OOI, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1